Compare RYAM & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | ZVRA |
|---|---|---|
| Founded | 1926 | 2006 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.8M | 472.9M |
| IPO Year | 2014 | 2015 |
| Metric | RYAM | ZVRA |
|---|---|---|
| Price | $10.23 | $10.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $14.00 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 702.7K | 663.0K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $1,466,397,000.00 | $106,470,000.00 |
| Revenue This Year | N/A | $37.27 |
| Revenue Next Year | $8.22 | $53.42 |
| P/E Ratio | ★ N/A | $7.70 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $3.35 | $6.85 |
| 52 Week High | $11.85 | $13.16 |
| Indicator | RYAM | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 68.59 |
| Support Level | $6.91 | $10.69 |
| Resistance Level | $11.62 | $11.19 |
| Average True Range (ATR) | 0.54 | 0.39 |
| MACD | -0.07 | 0.12 |
| Stochastic Oscillator | 51.16 | 91.29 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.